Catalysts for Appco Pharma LLC
10 tracked
Apr 8, 2026
recall
Appco Pharma LLC recall (Cls II)
Appco Pharma LLC
→
Apr 8, 2026
recall
Appco Pharma LLC recall (Cls II)
Appco Pharma LLC
→
Apr 8, 2026
recall
Appco Pharma LLC recall (Cls II)
Appco Pharma LLC
→
Mar 16, 2026
approval
ACAMPROSATE CALCIUM — FDA approval
acamprosate calcium DR
→
Feb 25, 2026
approval
HYDROCORTISONE — FDA approval
ET-800
→
Jan 20, 2026
approval
SERTRALINE HYDROCHLORIDE — FDA approval
SERTRALINE HYDROCHLORIDE
→
Nov 5, 2025
recall
Amerisource Health Services LLC recall (Cls II)
Appco Pharma LLC
→
Nov 5, 2025
recall
Amerisource Health Services LLC recall (Cls II)
Appco Pharma LLC
→
Nov 5, 2025
recall
Amerisource Health Services LLC recall (Cls II)
Appco Pharma LLC
→
Jan 29, 2025
recall
Appco Pharma LLC recall (Cls III)
Appco Pharma LLC
→